{"id":451,"date":"2025-10-06T20:18:16","date_gmt":"2025-10-06T23:18:16","guid":{"rendered":"https:\/\/ggac.com.br\/?p=451"},"modified":"2025-10-06T20:28:12","modified_gmt":"2025-10-06T23:28:12","slug":"negativa-ocrelizumabe","status":"publish","type":"post","link":"https:\/\/ggac.com.br\/en\/negativa-ocrelizumabe\/","title":{"rendered":"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-en\">Sorry, this entry is only available in <a href=\"https:\/\/ggac.com.br\/pb\/wp-json\/wp\/v2\/posts\/451\" class=\"qtranxs-available-language-link qtranxs-available-language-link-pb\" title=\"PT\">PT<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Sorry, this entry is only available in PT.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-451","post","type-post","status-publish","format-standard","hentry","category-artigos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer - GGAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer - GGAC\" \/>\n<meta property=\"og:description\" content=\"Sorry, this entry is only available in PT.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\" \/>\n<meta property=\"og:site_name\" content=\"GGAC\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T23:18:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-06T23:28:12+00:00\" \/>\n<meta name=\"author\" content=\"ggac\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ggac\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\"},\"author\":{\"name\":\"ggac\",\"@id\":\"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b\"},\"headline\":\"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer\",\"datePublished\":\"2025-10-06T23:18:16+00:00\",\"dateModified\":\"2025-10-06T23:28:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\"},\"wordCount\":440,\"articleSection\":[\"Articles\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\",\"url\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\",\"name\":\"[:pb]Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer[:] - GGAC\",\"isPartOf\":{\"@id\":\"https:\/\/ggac.com.br\/#website\"},\"datePublished\":\"2025-10-06T23:18:16+00:00\",\"dateModified\":\"2025-10-06T23:28:12+00:00\",\"author\":{\"@id\":\"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/ggac.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ggac.com.br\/#website\",\"url\":\"https:\/\/ggac.com.br\/\",\"name\":\"GGAC\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ggac.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b\",\"name\":\"ggac\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g\",\"caption\":\"ggac\"},\"url\":\"https:\/\/ggac.com.br\/en\/author\/ggac\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer - GGAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/","og_locale":"en_US","og_type":"article","og_title":"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer - GGAC","og_description":"Sorry, this entry is only available in PT.","og_url":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/","og_site_name":"GGAC","article_published_time":"2025-10-06T23:18:16+00:00","article_modified_time":"2025-10-06T23:28:12+00:00","author":"ggac","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ggac","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#article","isPartOf":{"@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/"},"author":{"name":"ggac","@id":"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b"},"headline":"(PT) Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer","datePublished":"2025-10-06T23:18:16+00:00","dateModified":"2025-10-06T23:28:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/"},"wordCount":440,"articleSection":["Articles"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/","url":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/","name":"[:pb]Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer[:] - GGAC","isPartOf":{"@id":"https:\/\/ggac.com.br\/#website"},"datePublished":"2025-10-06T23:18:16+00:00","dateModified":"2025-10-06T23:28:12+00:00","author":{"@id":"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b"},"breadcrumb":{"@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggac.com.br\/negativa-ocrelizumabe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ggac.com.br\/negativa-ocrelizumabe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ggac.com.br\/"},{"@type":"ListItem","position":2,"name":"Plano de sa\u00fade ou SUS negaram o medicamento Ocrevus (Ocrelizumabe) para Esclerose M\u00faltipla? Veja o que fazer"}]},{"@type":"WebSite","@id":"https:\/\/ggac.com.br\/#website","url":"https:\/\/ggac.com.br\/","name":"GGAC","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ggac.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ggac.com.br\/#\/schema\/person\/12f71c9369a78b9b67d3d89639c53d3b","name":"ggac","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24304dd18eb08e35346830efebcbb41978458c6a5062fe5ed6c8050150cd6a79?s=96&d=mm&r=g","caption":"ggac"},"url":"https:\/\/ggac.com.br\/en\/author\/ggac\/"}]}},"_links":{"self":[{"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/posts\/451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/comments?post=451"}],"version-history":[{"count":2,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/posts\/451\/revisions"}],"predecessor-version":[{"id":453,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/posts\/451\/revisions\/453"}],"wp:attachment":[{"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/media?parent=451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/categories?post=451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggac.com.br\/en\/wp-json\/wp\/v2\/tags?post=451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}